Target intelligence / Profile preview

novel transcript, antisense to SLC39A4 (ENSG00000272115)

Target
ENSG00000272115
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

Novel transcript, antisense to SLC39A4" (ENSG00000272115) denotes an uncharacterized non-coding RNA transcribed from the region opposite to the SLC39A4 gene, which encodes the zinc transporter ZIP4[1][3][7]. Antisense transcripts may regulate the expression of their sense gene partners via RNA interference or epigenetic mechanisms, but for ENSG00000272115, there is currently no known molecular function, biological role, disease association, or experimental evidence supporting its relevance as a drug target. It is not recognized as a receptor, transporter, enzyme, or other classical druggable entity. No aliases, clinical biomarkers, or reported interactions exist for this RNA. If a therapeutic or diagnostic interest in the antisense regulation of SLC39A4 emerges in the future, this could change, but at present, it should not be considered a canonical target.

Other names
antisense RNA to SLC39A4SLC39A4-AS

Beyond the preview

Go deeper on novel transcript, antisense to SLC39A4 (ENSG00000272115).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to SLC39A4 (ENSG00000272115).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call